Evidence map›Paper›PMID 39926105›Full record

ArticleJournal of clinical & translational endocrinology2025

Guoyang Zheng, Jie Ding, Yinjie Gao, Shengyan Liu, Xinchun Yan, Wenda Wang, Yang Zhao, Zhan Wang, Li Huo, Anli Tong and 1 more

Abstract read
In one paragraph

Article in Journal of clinical & translational endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. AVS-referenced diagnostic performance ofFrontiers in endocrinology · 2026
    Pooled it
  2. Real world experience with [Frontiers in endocrinology · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Guoyang ZhengDepartment of Urology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, 1st Shuaifuyuan Road, Dongcheng District, Beijing 100730 China.
Jie DingDepartment of Nuclear Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, 1st Shuaifuyuan Road, Dongcheng District, Beijing 100730 China.
Yinjie GaoDepartment of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, 1st Shuaifuyuan Road, Dongcheng District, Beijing 100730 China.
Shengyan LiuDepartment of Nuclear Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, 1st Shuaifuyuan Road, Dongcheng District, Beijing 100730 China.
Xinchun YanDepartment of Nuclear Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, 1st Shuaifuyuan Road, Dongcheng District, Beijing 100730 China.
Wenda WangDepartment of Urology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, 1st Shuaifuyuan Road, Dongcheng District, Beijing 100730 China.
Yang ZhaoDepartment of Urology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, 1st Shuaifuyuan Road, Dongcheng District, Beijing 100730 China.
Zhan WangDepartment of Urology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, 1st Shuaifuyuan Road, Dongcheng District, Beijing 100730 China.
Li HuoDepartment of Nuclear Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, 1st Shuaifuyuan Road, Dongcheng District, Beijing 100730 China.
Anli TongDepartment of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, 1st Shuaifuyuan Road, Dongcheng District, Beijing 100730 China.
Yushi ZhangDepartment of Urology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, 1st Shuaifuyuan Road, Dongcheng District, Beijing 100730 China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This study aimed to explore the significance of Materials and methods: We prospectively included 91 PA patients receiving surgical treatments based on the results of Results: The positive detection rate of Conclusions:

Indexed as

68Ga-pentixafor PET/CTAdrenalectomyCXCR4 receptorPrimary aldosteronism

Identifiers

PMID39926105
PMCPMC11803161

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.